Clinical trials
Lung Neoplasms trials in the United Kingdom with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Unknown status | 13 |
| Recruiting | 8 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Christie NHS Foundation Trust | 4 |
| Imperial College Healthcare NHS Trust | 2 |
| Royal Marsden NHS Foundation Trust | 2 |
| Sally Falk | 2 |
| The Clatterbridge Cancer Centre NHS Foundation Trust | 2 |
| University College, London | 2 |
| University of Hull | 2 |
| CSA Medical, Inc. | 1 |
| Endowave Ltd. | 1 |
| Golden Jubilee National Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 46 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Neoplasms | 4 |
| Colorectal Neoplasms | 3 |
| Lymphoma | 3 |
| Dyspnea | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Sarcoidosis | 2 |
| Small Cell Lung Carcinoma | 2 |
| Agnosia | 1 |
Trials
Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.